Related by context. All words. (Click for frequent words.) 71 non porcine pancreatic 70 orally administered synthetic retinoid 67 Taliglucerase alfa 63 Sudhir Agrawal D.Phil 63 primary humoral immunodeficiency 63 Halozyme recombinant human 61 metastatic malignant 61 cetuximab Erbitux R 61 Peginterferon alfa 2b 61 luteinizing hormone releasing 61 PEGylated anti 61 adalimumab Humira 61 Aflibercept 61 alfa 2a 61 aurora kinase 60 Luteinizing Hormone Releasing Hormone 60 CYT# potent vascular disrupting 60 hormone LHRH antagonist 60 Vidaza azacitidine 60 cutaneous T 60 CTAP# Capsules 60 chimeric monoclonal antibody 60 orally administered inhibitor 60 Degarelix 60 pamidronate 59 Viread tenofovir disoproxil fumarate 59 lymphomas leukemias 59 gemtuzumab ozogamicin 59 targeted antifolate 59 potent inducer 59 BCG refractory 59 targeted radiotherapeutic 59 Premarin hormone 59 anastrazole 59 advanced hepatocellular carcinoma 59 alkylating agent 59 pentostatin 59 dasatinib Sprycel ® 59 inhibitor COX 59 protein tyrosine phosphatase 1B 59 vinca alkaloid 59 novel VDA molecule 59 leukemia AML 59 Amgen Neulasta ® 59 chemosensitizer 59 metastatic carcinoma 59 injectable interferon 59 interleukin IL -# 59 oropharyngeal candidiasis OPC 59 receptor inhibiting monoclonal 59 Paraplatin ® 59 metastatic gastric 59 metastatic colorectal carcinoma 59 pathophysiological effects 59 LHRH receptor positive 59 selective modulator 59 papillary renal cell carcinoma 59 HER2 positive metastatic breast 59 factor G CSF 59 refractory cutaneous T 59 CYP#A# CYP#D# 59 radiolabeled TM# 58 depsipeptide 58 myelodysplastic myeloproliferative diseases 58 humanized interleukin 6 58 vinorelbine tartrate 58 hypereosinophilic syndrome 58 relapsed leukemia 58 bovine thrombin 58 nucleoside analog 58 Sapacitabine 58 hyaluronidase enzyme 58 Granulocyte Colony Stimulating Factor 58 intranasal formulation 58 refractory chronic lymphocytic 58 CEQ# 58 metaglidasen 58 Factor VIIa 58 essential thrombocythemia ET 58 MAGE A3 ASCI 58 SPRYCEL ® 58 non nucleoside inhibitor 58 thromboxane A2 58 Irinotecan 58 XYOTAX TM 58 demonstrated antitumor activity 58 syngeneic 58 GW# [003] 58 Vandetanib 58 plasma kallikrein inhibitor 58 recurrent glioblastoma multiforme 58 antifibrotic 58 nilotinib Tasigna 57 malignant ascites 57 metastatic hormone refractory 57 Raptiva R 57 bladder ovarian 57 Panzem R NCD 57 microtubule inhibitor 57 LymphoStat B belimumab 57 forodesine 57 MGd 57 goserelin 57 vaginal candidiasis 57 accumulate preferentially 57 polysaccharide polymer 57 Amgen Neulasta R 57 alefacept 57 VALSTAR 57 bevacizumab Avastin ® 57 Serostim ® 57 adefovir dipivoxil 57 MKC# MT 57 alpha1 antitrypsin AAT deficiency 57 Camptosar ® 57 cell lymphoma CTCL 57 Familial Adenomatous Polyposis FAP 57 Pharmacokinetics PK 57 Tarceva TM 57 radiotherapeutic 57 K ras mutations 57 unresectable locally advanced 57 NS5b 57 multiple myeloma MM 57 Janus kinase 57 Carcinoid tumors 57 formerly LymphoStat B 56 metastatic carcinoid 56 CTAP# 56 HepG2 cells 56 brivanib 56 Dacogen decitabine 56 LymphoStat B TM 56 cetuximab Erbitux 56 castrate resistant prostate cancer 56 chronic eosinophilic leukemia 56 vidofludimus 56 Clolar ® 56 relapsing remitting MS RRMS 56 refractory acute myeloid 56 CDK cyclin dependent 56 Alfacell proprietary ribonuclease 56 PKC# 56 TLR7 agonist 56 polycythemia vera essential thrombocythemia 56 FK# 56 surgical aortic valve 56 pan HDAC inhibitor 56 metastatic neuroendocrine tumors 56 bladder carcinoma 56 PSMA ADC 56 EGFr expressing metastatic colorectal 56 Enzastaurin 56 carcinoma HCC 56 Elotuzumab 56 administered intranasally 56 metastatic colorectal 56 aggressive systemic mastocytosis 56 Muraglitazar 56 busulfan 56 A1PI 56 prostate carcinoma 56 SNT-MC#/idebenone 56 Intravenous CP 56 Cloretazine 56 cell adhesion molecule 56 VEGF induced 56 Bezielle 56 IgG1 monoclonal antibody 56 radiation sensitizer 56 immunostimulatory 55 factor TNF 55 Raptiva ® 55 cisplatin resistant 55 nucleotide analog 55 basiliximab 55 imatinib Gleevec ® 55 ORENCIA R 55 ORENCIA ® 55 galiximab 55 beta estradiol 55 targets Galectin receptors 55 recombinant interferon 55 HER2 ErbB2 55 poly ADP ribose polymerase 55 erlotinib Tarceva 55 azacytidine 55 carbohydrate polymer 55 Adjuvant Treatment 55 antiproliferative effects 55 HuMax 55 heparanase 55 anaplastic lymphoma kinase ALK 55 CCR2 55 coagulation disorders 55 interferon IFN 55 PNP inhibitor 55 novel therapeutic antibodies 55 fluoropyrimidine 55 mRCC 55 receptor CXCR4 55 metastatic GIST 55 iobenguane 55 IAP inhibitor 55 calcineurin inhibitor 55 indinavir Crixivan 55 metastatic pancreatic 55 ALK inhibitor 55 alkylating agents 55 gastrointestinal stromal tumor GIST 55 Aviptadil 55 prostate adenocarcinoma 55 Pfizer Camptosar 55 subcutaneous immunoglobulin 55 Personalized Immunotherapy 55 hepatoma 55 oncolytic virus therapies 55 glutamic acid decarboxylase 54 KRAS oncogene 54 III EGFRvIII 54 binds selectively 54 chronic myeloid 54 nelfinavir Viracept 54 CLL SLL 54 soluble tumor necrosis 54 Intravenous Human 54 Dendreon investigational 54 huC# DM4 54 #I TM# 54 recombinant fusion 54 selectively inhibited 54 Recombinant interferon alpha 54 investigational immunotherapy 54 EGFR HER2 54 alpha folate receptor 54 malignant pleural mesothelioma 54 Cyclooxygenase 2 54 systemically administered 54 RRM1 54 hepatocellular carcinomas 54 methionine aminopeptidase 54 irinotecan oxaliplatin 54 p# MAPK 54 finasteride Proscar 54 Leydig cells 54 TNF α 54 anti PlGF 54 oral prodrug 54 anthracycline containing 54 pancreatic endocrine 54 myeloproliferative diseases 54 Proxinium TM 54 constitutively expressed 54 mutated K ras 54 Amigal 54 FOLFOX6 54 oral ghrelin agonist 54 subcutaneous fluid 54 sunitinib Sutent 54 agonistic human 54 Tumor Necrosis Factor 54 Monocyte 54 HCV replicon 54 Kinoid 54 Aplidin 54 haematologic malignancies 54 NPC 1C 54 antibody MAb 54 refractory gout 54 denileukin diftitox 54 TLR9 agonist 54 mouse xenograft models 54 HSP# inhibitor 54 ADAMTS# 54 pancreatic prostate 54 oligodendrocyte progenitor cells 54 IgM isotype 54 corticosteroid dexamethasone 54 paclitaxel Taxol 54 OMP #M# 54 monoclonal antibody IgG1 Mab 54 selectively binds 54 human IgG1 monoclonal 54 lymphoid malignancies 54 enkephalin 54 fallopian tube cancers 54 HIV coinfected 54 HBeAg negative 54 saline placebo 54 plasmid encoding 54 LHRH antagonist 54 cholesteryl ester transfer 54 Factor Receptor 53 Vicinium TM 53 Onrigin 53 castrate resistant 53 BARACLUDE ® 53 metastatic bladder 53 alpha fetoprotein AFP 53 alvespimycin 53 Domenik Hixon Burress 53 HER2 HER2 53 paclitaxel cisplatin 53 gastrointestinal stromal tumors GISTs 53 OMP #R# 53 Immunotherapeutic 53 mutated KRAS 53 AGTR1 53 Apaziquone 53 TRO# 53 hormone LHRH 53 alemtuzumab Campath 53 chlorambucil 53 Annamycin 53 acid phosphatase PAP 53 systemic anaplastic large 53 tumorigenicity 53 TNF blocker therapy 53 pediatric acute lymphoblastic 53 receptor blocker 53 factor receptor EGFr 53 HCV polymerase 53 imatinib Gleevec 53 aplastic anemia AA 53 ERalpha 53 opioid induced constipation OIC 53 androgen receptor AR 53 potently inhibit 53 IMA# 53 ERK1 2 53 CCR9 53 percutaneous aortic valve 53 penile erectile tissue 53 complete cytogenetic response 53 Rituxan rituximab 53 alpha2 53 protease inhibitor PI 53 adrenoceptor 53 generation antisense inhibitor 53 Zarnestra 53 neoplastic cells 53 humanized anti 53 UPLYSO 53 hPAM4 53 Kinase Inhibitor 53 mediated inhibition 53 Clusterin 53 untreated metastatic melanoma 53 ovarian breast 53 virus HCV protease inhibitor 53 Gleevec resistant 53 sodium thiosulfate STS 53 idiopathic membranous nephropathy 53 natural bioidentical hormone 53 CDK inhibitor 53 Grb 2 53 Julian Edelman Welker 53 Epstein Barr Virus EBV 53 Epidermal Growth Factor Receptor 53 colorectal carcinoma 53 retinoic acid receptor 53 colorectal adenocarcinoma 53 tNOX 53 ovarian endometrial 53 cis RA 53 acute myelogenous leukemia AML 53 HuLuc# 53 NTDDS 53 MyVax R 53 refractory multiple myeloma 53 HER2 overexpression 53 DNA hypermethylation 53 whose tumors overexpress 53 GVAX R 53 Nexavar sorafenib 53 HER2 expression 53 Prempro hormone 53 Fibroblast 53 chemoresistant 53 deletion 5q 53 anthracycline chemotherapy 53 specific lectin receptors 52 SGLT2 52 haematopoietic stem cell 52 induces apoptosis 52 breast pancreatic 52 mda 7 52 trastuzumab Herceptin ® 52 systemic ALCL 52 LHRH 52 tryptase 52 NS#/#A protease 52 PhG alpha 1 52 HBeAg positive patients 52 antiangiogenic agent 52 metastatic liver 52 HLA DQ2 52 recurrent metastatic 52 Trofex 52 progesterone receptor negative 52 chemopreventive agent 52 SCIg 52 Trastuzumab Herceptin 52 receptor tyrosine kinase inhibitor 52 targeting CD# 52 nonmetastatic 52 Melphalan 52 TRAIL receptor 52 androgen independent 52 HER2 amplification 52 TNFa 52 EGFR TKI 52 cMET 52 pmol L 52 redox active 52 diagnostic biomarker 52 NeoLipid R 52 Upregulation 52 ALK inhibitors 52 CD8 + cytotoxic 52 metalloproteinase 52 Alphanate R 52 Glioblastoma Multiforme 52 cytotoxic T lymphocyte 52 Insegia 52 trivalent inactivated influenza 52 EDV SV waste 52 Achieves Primary Endpoint 52 SSc 52 castration resistant 52 investigational monoclonal antibody 52 ASONEP ™ 52 monocyte chemoattractant protein 52 ABCB1 52 TNFalpha 52 interferon lambda 52 GRNVAC1 52 cytoprotective 52 SIR Spheres 52 sipuleucel T 52 carcinoembryonic antigen 52 liposomal doxorubicin 52 MENOPUR ® 52 hormone receptor negative 52 thyroid hormone receptor 52 TGF alpha 52 colon carcinoma 52 tumors GIST 51 cytochrome P 51 endocrine therapies 51 CsA 51 interferon γ 51 Quinamed 51 pDCs 51 stage IIIb IV 51 therapeutic monoclonal antibody 51 PNT# 51 alpha#beta# 51 gastric carcinoma 51 pancreatic lung 51 CD#c 51 pancreatic adenocarcinoma 51 Balamuthia 51 irreversible inhibitor 51 bacterial biothreat agents 51 somatostatin 51 cyclooxygenase 51 non mutated KRAS 51 MCSP respectively 51 chemokine receptor 51 mutated KRAS gene 51 HER1 51 IGF1R 51 5alpha reductase 51 cetuximab Erbitux ® 51 ALDH 51 GRN# 51 CTL epitopes 51 cytoreduction 51 inducible nitric oxide synthase 51 replicon 51 BRAF mutant 51 tipranavir ritonavir 51 TIMP 51 IFN g 51 SERMs 51 IFN alpha 2a 51 TRAIL R2 51 TransVax ™ 51 DAVANAT 51 upregulates 51 Aplidin R 51 transmembrane receptor 51 HERCEPTIN 51 potent inducers 51 NYSE AG www.agcocorp.com 51 Aurora kinase 51 HER2 receptor 51 refractory Hodgkin 51 pancreatic carcinoma 51 Her2 positive 51 cervical vulvar 51 pretransplant 51 hA# 51 compound AEZS 51 refractory metastatic 51 IL #R 51 SOD1 gene 51 Human papillomavirus 51 FLT3 51 Fibroblast Growth Factor Receptor 51 castration resistant prostate cancer 51 albumin bound paclitaxel 51 intradermal injection 51 Pralatrexate 51 HGPIN 51 immunodeficient 51 peptide antigens 51 hormone receptor positive 51 nonnucleoside reverse transcriptase inhibitors 51 Mucosal 51 promoter methylation 51 refractory colorectal cancer 51 Angiolix 51 pancreatic ovarian 51 thymidine kinase 51 cancer immunotherapeutics 51 TTR gene 51 ALB # 51 HepaGam B 51 selective kinase inhibitor 51 RhD positive 51 GSTP1 50 potently inhibited 50 NSCLC tumors 50 somatostatin receptors 50 mitogenic 50 lamivudine resistant 50 NP2 50 humanized antibody 50 RAV# 50 glucocerebrosidase GCD 50 novel immunotherapeutic 50 activin 50 inhibit vascular endothelial 50 Thiovir 50 virus AAV 50 human chorionic gonadotropin hCG 50 IL 1ß 50 monocytes macrophages 50 chlamydial 50 #beta 50 BMP2 50 adjuvant cisplatin 50 MDR1 50 metastatic renal cell 50 hCG β 50 GARDASIL ® 50 transgenic rats 50 L asparaginase 50 FOLFIRI alone 50 DNA intercalator 50 gastric adenocarcinoma 50 degeneration gastrointestinal disorders 50 synovial tissue 50 Cytotoxic T 50 IGFBP 3 50 Pafuramidine 50 tumor specific antigen 50 inhibit replication 50 TNF Blockers 50 progesterone receptor 50 Theratope 50 myeloperoxidase 50 ERCC1 50 TRAIL Receptor 50 neovasculature 50 hypermethylated 50 HealthGrades Joint 50 indolent follicular non 50 intraepithelial neoplasia 50 renal cysts 50 arterial aneurysms 50 invasive lobular 50 ovarian colon 50 HGS ETR2 50 florbetaben 50 HER2 negative 50 ALT normalization 50 E selectin 50 mcg dose 50 GPNMB 50 HER2 amplified 50 signal transduction inhibitors 50 HBsAg 50 COL#A# 50 chronic HBV 50 oblimersen 50 KRAS status 50 antibody MT# 50 glucose transporter 50 Therapeutic Vaccine 50 KIF6 gene 50 effector function 50 cytokeratin 50 BiTE ® 50 cervical breast 50 skeletal metastases 50 Ceflatonin 49 antiestrogen 49 colorectal pancreatic 49 aberrantly activated 49 CEACAM1 49 refractory gastrointestinal stromal 49 anti EGFR antibody 49 anti CD3 49 plasmid DNA pDNA 49 hENT1 49 DCVax R 49 immunodeficiency disorders 49 FGFR2 49 HAAH 49 cytostatic 49 Antigenics QS 49 chemokine receptors 49 thyroid peroxidase 49 lysyl oxidase 49 lymphocytosis 49 MVA BN 49 Travis Zajac Johnny Oduya 49 MyVax ® 49 humanized monoclonal antibodies 49 glutamic acid decarboxylase GAD 49 Alferon LDO 49 annexin 49 HER2 neu 49 T1c 49 E#F# 49 Th2 cytokines 49 KRAS mutations 49 percutaneous mitral valve 49 OncoVEX GM CSF 49 unresectable inoperable 49 colorectal ovarian 49 BRAF V#E mutation 49 WT1 49 MAGE A3 protein 49 K#R [002] 49 ligand TRAIL 49 intratumoral injection 49 eIF 4E 49 immunotherapeutic vaccine 49 B CLL 49 publicists Mara Buxbaum 49 Cloretazine R 49 ankle arthrodesis 49 angiotensin receptor 49 BRCA deficient 49 colorectal bladder 49 Dacron graft 49 NKX#.# 49 regenerating cartilage 49 underwent elbow ligament 49 neoadjuvant setting 49 Paula Abdul proclaiming 49 recurrent ovarian 49 hCG Beta 49 lysophosphatidic acid LPA 49 intranasal delivery 49 cytotoxic effects 49 cervical intraepithelial neoplasia 49 tissue transglutaminase 49 CMV disease 49 M2 subunit 49 Pentacel vaccine 49 epithelial cells lining 49 HER2/neu 49 achieved sustained virological 49 cathepsins 49 surface glycoprotein 48 glycosylated 48 cartilaginous tissue 48 caloric dietary fiber 48 CD# molecule 48 EGFR inhibitors 48 DGAT1 48 Thales tubes 48 C5aR 48 mCRC patients 48 chronic HBV infection 48 EpCAM 48 PDGF receptor 48 transapical aortic valve 48 downregulated 48 CYC# 48 NS4A 48 Exherin TM 48 IDH mutations 48 receptor inhibitors 48 Li Fraumeni 48 EGFR mutation positive 48 HyperAcute 48 ERBB2 48 neuroblastoma tumors 48 tumor antigen 48 advanced pancreatic neuroendocrine 48 folate receptor 48 Davanat 48 OncoVex 48 cyclin dependent kinase 48 cellular immunotherapy 48 receptor alpha 48 CD# + [001] 48 ErbB 48 TOP2A 48 RNAi therapeutic targeting 48 MVA MUC1 IL2 48 mesothelin 48 autocrine 48 intercellular adhesion molecule 48 CYP#B# 48 KRAS mutant 48 Mesothelin 48 annexin V 48 recombinant adeno associated 48 petrol LRP 48 hepatitis C HCV 48 VEGF receptor 48 ErbB3 48 A3 adenosine receptor 48 IGFBP 48 mutated p# 48 SPINK1 48 serum antibody 48 EGFR tyrosine kinase inhibitors 48 p#NTR 48 S/GSK# 48 carcinoembryonic antigen CEA 48 EGFR protein 48 prostate cancer CaP 48 mouse mammary tumor 48 Nikolai V. Podgorny 48 Aurexis 48 cytolytic 48 basophils 48 NKG2D 48 pancreatic islet 48 immunohistochemical staining 48 N cadherin 48 CCL# 48 CanAg 48 bendamustine HCl 48 XmAb ® 48 T#I [002] 47 metastatic malignant melanoma 47 potent cytotoxic 47 orthotopic model 47 induces antibodies 47 inhibit EGFR 47 Toxoid 47 colorectal carcinomas 47 p# mitogen activated 47 telomerase reverse transcriptase 47 selectively inhibit 47 Samuel Whitelock 47 EGF receptor 47 ovarian carcinoma 47 bispecific 47 PC# cells 47 XL# inhibits 47 MAb 47 IMC A# 47 humoral responses 47 HER2 positive cancers 47 oral squamous cell 47 vimentin 47 VP# [004] 47 CD#L 47 prostate cancer antigen prostatic 47 CTGF 47 GAP #B# 47 bispecific antibody 47 IGF IR 47 pT2 47 c MYC 47 p# antigen 47 Corgentin 47 lipohypertrophy 47 MGMT gene 47 extracellular domain 47 estrogen receptor progesterone receptor 47 c myc 47 TroVax ® 47 undergoing elbow ligament 47 Chris Kanarick 47 e antigen HBeAg 47 stranded oligonucleotides 47 tyrosine kinase receptor 47 MET amplification 47 Shc 47 mutant p# 47 Î ² 47 MLL AF9 47 murine 47 tumor xenografts 47 oncogenic HPV 47 replacement TAVR 47 Scott Clemmensen Brodeur 47 Edwards SAPIEN transcatheter 46 bone cements 46 MAGE A3 46 malfunctioning pacemakers 46 serum biomarker 46 intramuscular IM 46 inhibit metastasis 46 HDAC EGFR 46 Immunohistochemical analysis 46 antigen CD# 46 TRAIL receptors 46 TrkA 46 breast carcinomas 46 nasal carriage 46 Epstein Barr virus EBV 46 KRAS mutated 46 alveolar epithelial cells 46 Anastas I. Mikoyan 46 interferon beta 46 malignant ovarian 46 endoglin 46 ChR2 46 hemiarthroplasty 46 adenoviral 46 PAR1 46 Survivin 46 microvascular endothelial cells 46 iNOS 46 humanized monoclonal antibody 46 cells overexpressing 46 LHRH receptors 46 p#INK#a 46 ERa 46 nodal metastasis 46 Vaxfectin R formulated 46 B7 H4 46 osteopontin 46 aT cell 46 HBeAg negative patients 46 HIV reverse transcriptase 46 EGFr 46 INDUSTRY MARKET 46 renal fibrosis 46 epithelial tumors 46 Lyn kinase 46 p# deficient 46 caveolin 1 46 superantigens 46 activating mutations 46 invasive carcinoma 46 TLR antagonist 46 EGFR TK 46 unhooked floor mats 46 Plasmid DNA 46 ribonucleotide reductase clinically validated 46 Melvin Bullitt Sanders 46 VEGFR1 46 cytomegalovirus CMV 46 isotype 46 Her2/neu 45 Associated Diarrhea 45 factor receptor EGFR 45 receptor CD# 45 oxysterols 45 NY ESO 45 Trp p8 45 pyruvate kinase 45 cancer mCRC 45 Cerf TCP IP 45 NRTI resistance 45 GPC5 45 specific membrane antigen 45 PSMA protein 45 GM CSF 45 leukaemias 45 estrogen receptor ER 45 Transgenic Mice 45 FGFR1 45 EGFRvIII 45 T#I mutation 45 Lymph node 45 NQO1 45 Including DIY Inst 45 E7 proteins 45 cervical lymph node 45 sphingosine 1 45 TNFα 45 HPV subtypes 45 VSV G 45 transcatheter aortic valve 45 P selectin 45 Injectable Suspension 45 Alyssa Mastromonaco whose 45 thyroid carcinomas 45 receptor tyrosine kinase 45 cartilage defect 45 Galectins 45 mutated BRAF gene 45 inhibitory receptor 45 neuroendocrine cancers 45 KRAS mutation 45 MUC1 45 IgG antibodies 45 SOX9 45 CardioWest TM 45 colorectal gastric 45 cytopathic 45 HER2 receptors 45 expiring Strategic Arms 45 KIT mutations 45 Human papillomavirus HPV 45 MVA BN ® 45 antibody titer 45 hCG beta 45 constitutively active 45 gastric carcinomas 45 Ki# 45 macrophage colony stimulating 45 EGFR mutations 45 percutaneous aortic 45 Oncolytic 45 CD# expression [001] 45 CD# antigen 45 metastatic prostate 45 Her-2/neu 44 BRAF mutation 44 CXCR4 receptor 44 receptors EGFR 44 #T# tumor 44 p# INK4a 44 CD4 receptor 44 HER-2/neu 44 HER2/neu protein 44 anti idiotype 44 HER2 protein 44 oxidized zirconium 44 TGF β 44 lymphoid organs 44 IFN γ 44 plasmacytoid dendritic cells 44 DNA methylation biomarkers 44 reconfigurable MOS logic 44 N. gonorrhoeae 44 RASSF1A 44 LNCaP cells 44 co stimulatory molecules 44 PC3 cells 44 PKCi 44 DLL4 44 precursor lesions 44 tumor lysate 44 HBeAg 44 deputy Debbie LeHardy 44 HEK# cells 44 Ankara MVA 44 idiotype vaccines 44 transfected 44 chlamydial infection 44 tricuspid valve repair 44 adenoviral vectors 44 uPAR 43 Pneumocystis carinii pneumonia 43 Replacements Andrew Hore 43 activated lymphocytes 43 p# mutation 43 replacement PAVR 43 cyclin E 43 Sapien THV 43 ErbB2 43 virus HBV 43 chloroflourocarbons 43 P#X# 43 Tubal ligation 43 node metastasis 43 mutant KRAS 43 pDNA vaccines 43 p#HER# 43 lentiviral vector 43 minimally invasive aortic valve 43 FasL 43 BioOil Plus 43 HER2/neu gene 43 seronegative 43 c Src 43 Pim kinases 43 coating implantable fixation 43 LHRH receptor 43 similarly captioned 43 epithelial cell 43 uterine ovarian 43 envelope glycoprotein